IHL - INCANNEX - HOLDERS RESEARCH, page-824

Don't be surprised if Incannex's pivot to the USA Investor Audience comes into focus in the coming days/weeks.

>> A huge company milestone is inbound IMO
Filing an IND with the FDA in the USA for our IHL-42X Phase 2 / 3 Trials, based in the USA.
This will be IHL's first FDA-monitored and USA-based Phase 2/ 3 Trials.

>> Re-directing our Incannex Website Domain from .com.au to now .com only, maybe in preparation for a new USA audience too!



Good luck to all holders